Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial

131

Citations

47

References

2021

Year

Tien Dam, Adam L. Boxer, Lawrence I. Golbe, Günter U. Höglinger, Huw R. Morris, Irene Litvan, Anthony E. Lang, Jean‐Christophe Corvol, Ikuko Aiba, Michael Grundman,

Nature Medicine

RheumatologyProgressive Supranuclear PalsyPlacebo-controlled TrialPhase 2MedicineOrthopaedic Surgery

References

	Year	Citations

Page 1